Search

Your search keyword '"Aliberti, Ludovica"' showing total 28 results
Start Over Author "Aliberti, Ludovica"
Sorry, I don't understand your search. ×
28 results on '"Aliberti, Ludovica"'

8. Rationale and protocol of a double-blind, randomized, placebo-controlled trial to test the efficacy, safety, and tolerability of dimethyl fumarate in Friedreich Ataxia (DMF-FA-201)

Author

Pane, Chiara, primary, Marra, Alberto Maria, additional, Aliberti, Ludovica, additional, Campanile, Mario, additional, Coscetta, Federica, additional, Crisci, Giulia, additional, D'Assante, Roberta, additional, Marsili, Angela, additional, Puorro, Giorgia, additional, Salzano, Andrea, additional, Cittadini, Antonio, additional, and Saccà, Francesco, additional

Published
2023
Full Text
View/download PDF

9. Pituitary apoplexy and COVID-19 vaccination: a case report and literature review

Author

Aliberti, Ludovica, Gagliardi, Irene, Rizzo, Roberta, Bortolotti, Daria, Schiuma, Giovanna, Franceschetti, Paola, Gafà, Roberta, Borgatti, Luca, Cavallo, Michele A., Zatelli, Maria C., and Ambrosio, Maria R.

Subjects
Endocrinology, Diabetes and Metabolism
Abstract

A 50-year-old man was admitted to our hospital for vomit, nausea, diplopia, and headache resistant to analgesic drugs. Symptoms started the day after his third COVID-19 mRNA vaccine (Moderna) whereas SARS-CoV-2 nasal swab was negative. Pituitary MRI showed recent bleeding in macroadenoma, consistent with pituitary apoplexy. Adverse Drug Reaction was reported to AIFA (Italian Medicines Agency).A stress dexamethasone dose was administered due to the risk of adrenal insufficiency and to reduce oedema. Biochemistry showed secondary hypogonadism; inflammatory markers were elevated as well as white blood cells count, fibrinogen and D-dimer. Pituitary tumour transsphenoidal resection was performed and pathology report was consistent with pituitary adenoma with focal haemorrhage and necrosis; we found immunohistochemical evidence for SARS-CoV-2 proteins next to pituitary capillaries, in the presence of an evident lymphocyte infiltrate.Few cases of pituitary apoplexy after COVID-19 vaccination and infection have been reported. Several hypotheses have been suggested to explain this clinical picture, including cross-reactivity between SARS-CoV-2 and pituitary proteins, COVID-19-associated coagulopathy, infection-driven acutely increased pituitary blood demand, anti-Platelet Factor 4/heparin antibodies development after vaccine administration. Ours is the first case of SARS-CoV-2 evidence in pituitary tissue, suggesting that endothelial infection of pituitary capillaries could be present before vaccination, possibly due to a previous asymptomatic SARS-CoV-2 infection. Our case underlines that SARS-CoV-2 can associate with apoplexy by penetrating the central nervous system, even in cases of negative nasal swab. Patients with pituitary tumours may develop pituitary apoplexy after exposure to SARS-CoV-2, therefore clinicians should be aware of this risk.

Published
2022
Full Text
View/download PDF

13. MEN1 gene sequence variant C.[527 G > A] P.[ARG 176 GLN]: Is it pathogenic?

Author

Zanata, Isabella, Crociara, Anna, Ambrosio, Maria Rosaria, Bondanelli, Marta, Aliberti, Ludovica, Gagliardi, Irene, Tamburini, Nicola, and Zatelli, Maria Chiara

Subjects
men1c.[527 g &gt, a] p.[arg 176 gln]sequence variant, +a]+p%2E[arg+176+gln]sequence+variant%22">men1c.[527 g > a] p.[arg 176 gln]sequence variant, NO
Published
2022

14. Bone health in adolescence

Author

AMBROSIO, Maria R., primary, ALIBERTI, Ludovica, additional, GAGLIARDI, Irene, additional, FRANCESCHETTI, Paola, additional, and ZATELLI, Maria C., additional

Published
2021
Full Text
View/download PDF

15. Spontaneously reversible adrenal nodules in primary diffuse large B-cell testicular lymphoma mimicking an extranodal involvement: A case report

Author

Pellegrino, Fabio, primary, Scabbia, Francesca, additional, Merlo, Annalisa, additional, Perrucci, Luca, additional, Aliberti, Ludovica, additional, Urso, Antonio, additional, Ambrosio, Maria Rosaria, additional, Cuneo, Antonio, additional, Galeotti, Roberto, additional, and Giganti, Melchiore, additional

Published
2021
Full Text
View/download PDF

16. Hypeprolactinemia: still an insidious diagnosis

Author

Aliberti, Ludovica, primary, Gagliardi, Irene, additional, Dorizzi, Romolo M., additional, Pizzicotti, Stefano, additional, Bondanelli, Marta, additional, Zatelli, Maria Chiara, additional, and Ambrosio, Maria Rosaria, additional

Published
2020
Full Text
View/download PDF

23. Gestione dei prodotti chimici e normativa europea: nuovi criteri di classificazione secondo il regolamento 1272/2008 (CLP).

Author

Di Prospero Fanghella, Paola and Aliberti, Ludovica Malaguti

Subjects
*EUROPEAN Union law, *RISK assessment -- Law & legislation, *SAFETY regulations, *PACKAGING laws, *LABELING laws
Abstract

The article discusses a study related to the European Union which adopted regulations (EC) REACH, and (EC) CLP to manage the chemicals. Topics discussed include REACH requires for evaluation and management of risks which are related to the use of chemical substances, CLP provides for the classification, labeling and packagings of dangerous substance, and European downstream regulations including health and safety laws.

Published
2013

27. [Management of chemical products and European standards: new classification criteria according to the 1272/2008 (CLP) regulation].

Author

Fanghella PD and Aliberti LM

Subjects
European Union, Chemical Industry legislation & jurisprudence, Chemical Industry standards
Abstract

The European Union adopted regulations (EC) 1907/2006 REACH e (EC)1272/2008 CLP, to manage chemicals. REACH requires for evaluation and management of risks connected to the use of chemical substances, while o CLP provides for the classification, labelling and packagings of dangerous substances and mixtures by implementing in the EU the UN Globally Harmonised System of Classification and Labelling applying the building block approach, that is taking on board the hazard classes and categories which are close to the existing EU system in order to maintain the level of protection of human health and environment. This regulation provides also for the notification of the classification and labelling of substances to the Classification & Labelling Inventory established by the European Chemicals Agency (ECHA). Some european downstream regulations making reference to the classification criteria, as the health and safety laws at workplace, need to be adapted to these regulations.

Published
2013

28. The National helpdesk activity in Italy: report of the first year (2010).

Author

Aliberti LM and Izzo P

Subjects
Databases, Factual, Documentation, Government Agencies, Industry, Internet, Italy, Environmental Policy, Hazardous Substances classification, Information Services organization & administration
Abstract

National CLP heldpesk is a service established in every Member State providing advice to companies and other stakeholders on the obligations they may have under CLP. In Italy the national helpdesk is located into the Center of Chemical Substances (CSC) in the National Institute of Health. Helpdesks will provide with wide ranging information on the provisions of CLP. They will also advice on the responsibilities the suppliers of chemical substances have to fulfill under these Regulations. Too specific questions cannot be answered as the aim of the helpdesk is to give a general interpretation of CLP principles and requirements instead of solving tailor made problems.

Published
2011
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results